Position in XFOR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$49,445
+$40,727 QoQ
Shares Held
10,588
+760.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 89 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XFOR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $337,381,357 across 175 Biotechnology names. XFOR ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in XFOR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,445 | 10,588 | Shares | Sole | 2026-08-11 | |
| 2025-03-31 | $8,718 | 36,941 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $34,736 | 47,325 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $42,485 | 63,506 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,731 | 16,779 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $31,284 | 22,507 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $17,097 | 20,378 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $17,434 | 15,995 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $31,065 | 16,013 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||